{"transactions":[{"id":721413,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T17:41:50.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":18.32,"value":916000.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $18.29 to $18.32. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF."}],"balance_after":3186576,"source":{"system":"sec-edgar","filing":"0001104659-26-079793","document":"tm2619552-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926079793/tm2619552-2_4seq1.xml","form_type":"4"}},{"id":1012109,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-29T12:00:22.000Z","date":"2025-10-27","kind":"purchase","planned":false,"acquired":true,"shares":72836,"price":6.28,"value":457410.08,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF."}],"balance_after":3136576,"source":{"system":"sec-edgar","filing":"0001104659-25-103522","document":"tm2529599-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925103522/tm2529599-1_4seq1.xml","form_type":"4"}},{"id":1012108,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-29T12:00:22.000Z","date":"2025-10-24","kind":"purchase","planned":false,"acquired":true,"shares":35034,"price":6.15,"value":215459.1,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF."}],"balance_after":3063740,"source":{"system":"sec-edgar","filing":"0001104659-25-103522","document":"tm2529599-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925103522/tm2529599-1_4seq1.xml","form_type":"4"}},{"id":1012107,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-29T12:00:22.000Z","date":"2025-10-23","kind":"purchase","planned":false,"acquired":true,"shares":46900,"price":6.06,"value":284214.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF."}],"balance_after":3028706,"source":{"system":"sec-edgar","filing":"0001104659-25-103522","document":"tm2529599-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925103522/tm2529599-1_4seq1.xml","form_type":"4"}},{"id":1102771,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:14:35.000Z","date":"2025-06-20","kind":"purchase","planned":false,"acquired":true,"shares":5603,"price":7.99,"value":44767.97,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2981806,"source":{"system":"sec-edgar","filing":"0001104659-25-062168","document":"tm2518659-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925062168/tm2518659-1_4seq1.xml","form_type":"4"}},{"id":1105160,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T13:50:29.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":28043,"price":8.05,"value":225746.15,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $7.91 to $8.11. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2976203,"source":{"system":"sec-edgar","filing":"0001104659-25-060965","document":"tm2518418-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925060965/tm2518418-1_4seq1.xml","form_type":"4"}},{"id":1105159,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T13:50:29.000Z","date":"2025-06-17","kind":"purchase","planned":false,"acquired":true,"shares":5399,"price":8.11,"value":43785.89,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2948160,"source":{"system":"sec-edgar","filing":"0001104659-25-060965","document":"tm2518418-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925060965/tm2518418-1_4seq1.xml","form_type":"4"}},{"id":1151013,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-13T22:36:36.000Z","date":"2025-05-12","kind":"purchase","planned":false,"acquired":true,"shares":21167,"price":8.11,"value":171664.37,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.11 to $8.12. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2942761,"source":{"system":"sec-edgar","filing":"0001104659-25-047938","document":"tm2514962-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925047938/tm2514962-1_4seq1.xml","form_type":"4"}},{"id":1152357,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T13:25:24.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":5395,"price":8.976,"value":48425.52,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2936594,"source":{"system":"sec-edgar","filing":"0001104659-25-047089","document":"tm2514779-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925047089/tm2514779-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-09"}},{"id":1152356,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T13:25:24.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":9817,"price":8.9041,"value":87411.5497,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2931199,"source":{"system":"sec-edgar","filing":"0001104659-25-047089","document":"tm2514779-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925047089/tm2514779-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-09"}},{"id":1152355,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T13:25:24.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":9850,"price":8.947,"value":88127.95,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2921382,"source":{"system":"sec-edgar","filing":"0001104659-25-047089","document":"tm2514779-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925047089/tm2514779-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-09"}},{"id":1152354,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T13:25:24.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":2400,"price":8.97,"value":21528.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2911532,"source":{"system":"sec-edgar","filing":"0001104659-25-047089","document":"tm2514779-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925047089/tm2514779-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-09"}},{"id":1152353,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T13:25:24.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":8.71,"value":871.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2909132,"source":{"system":"sec-edgar","filing":"0001104659-25-047089","document":"tm2514779-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925047089/tm2514779-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-09"}},{"id":1152352,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T13:25:24.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":8.99,"value":899.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2909032,"source":{"system":"sec-edgar","filing":"0001104659-25-047089","document":"tm2514779-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925047089/tm2514779-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-05-09"}},{"id":1153885,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:53:19.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":2400,"price":8.65,"value":20760.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2911532,"source":{"system":"sec-edgar","filing":"0001104659-25-046882","document":"tm2514669-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046882/tm2514669-1_4seq1.xml","form_type":"4"}},{"id":1153884,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:53:19.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":8.65,"value":865.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2909132,"source":{"system":"sec-edgar","filing":"0001104659-25-046882","document":"tm2514669-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046882/tm2514669-1_4seq1.xml","form_type":"4"}},{"id":1153883,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:53:19.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":8.65,"value":865.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2909032,"source":{"system":"sec-edgar","filing":"0001104659-25-046882","document":"tm2514669-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046882/tm2514669-1_4seq1.xml","form_type":"4"}},{"id":1153882,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:53:19.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":50,"price":8.65,"value":432.5,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2908932,"source":{"system":"sec-edgar","filing":"0001104659-25-046882","document":"tm2514669-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046882/tm2514669-1_4seq1.xml","form_type":"4"}},{"id":1153881,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:53:19.000Z","date":"2025-05-07","kind":"purchase","planned":false,"acquired":true,"shares":9614,"price":8.64,"value":83064.96,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2908882,"source":{"system":"sec-edgar","filing":"0001104659-25-046882","document":"tm2514669-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046882/tm2514669-1_4seq1.xml","form_type":"4"}},{"id":1153880,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:53:19.000Z","date":"2025-05-07","kind":"purchase","planned":false,"acquired":true,"shares":2703,"price":8.4,"value":22705.2,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2899268,"source":{"system":"sec-edgar","filing":"0001104659-25-046882","document":"tm2514669-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046882/tm2514669-1_4seq1.xml","form_type":"4"}},{"id":1153879,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:53:19.000Z","date":"2025-05-06","kind":"purchase","planned":false,"acquired":true,"shares":10104,"price":8.64,"value":87298.56,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2896565,"source":{"system":"sec-edgar","filing":"0001104659-25-046882","document":"tm2514669-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046882/tm2514669-1_4seq1.xml","form_type":"4"}},{"id":1153878,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:53:19.000Z","date":"2025-05-06","kind":"purchase","planned":false,"acquired":true,"shares":2340,"price":8.4,"value":19656.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2886461,"source":{"system":"sec-edgar","filing":"0001104659-25-046882","document":"tm2514669-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046882/tm2514669-1_4seq1.xml","form_type":"4"}},{"id":1274230,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T22:58:35.000Z","date":"2025-02-07","kind":"purchase","planned":false,"acquired":true,"shares":240000,"price":5,"value":1200000.0,"ownership":{"direct":false,"nature":"By Emerald Hill Ventures SARL SPF."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL."}],"balance_after":2884121,"source":{"system":"sec-edgar","filing":"0001104659-25-011588","document":"tm256199-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925011588/tm256199-1_4seq1.xml","form_type":"4"}},{"id":1331014,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T22:37:54.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":17000,"price":4.7,"value":79900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4, filed on December 16, 2024, is being amended by this Form 4 amendment to include a transaction that occurred on December 12, 2024, and to correct the amount of securities beneficially owned by the reporting person as a result of the reported transactions."}],"balance_after":2644121,"source":{"system":"sec-edgar","filing":"0001104659-24-129009","document":"tm2431244-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924129009/tm2431244-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-12-16"}},{"id":1331013,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T22:37:54.000Z","date":"2024-12-12","kind":"purchase","planned":false,"acquired":true,"shares":32121,"price":4.64,"value":149041.44,"ownership":{"direct":true},"balance_after":2627121,"source":{"system":"sec-edgar","filing":"0001104659-24-129009","document":"tm2431244-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924129009/tm2431244-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-12-16"}},{"id":1331012,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T13:00:06.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":17000,"price":4.7,"value":79900.0,"ownership":{"direct":true},"balance_after":2612000,"source":{"system":"sec-edgar","filing":"0001104659-24-128688","document":"tm2431126-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924128688/tm2431126-1_4seq1.xml","form_type":"4"}},{"id":1819391,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-01T12:00:07.000Z","date":"2023-07-31","kind":"purchase","planned":false,"acquired":true,"shares":860,"price":13.88,"value":11936.8,"ownership":{"direct":true},"balance_after":2595000,"source":{"system":"sec-edgar","filing":"0001104659-23-086060","document":"tm2322480-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923086060/tm2322480-1_4seq1.xml","form_type":"4"}},{"id":1820535,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-31T12:00:09.000Z","date":"2023-07-28","kind":"purchase","planned":false,"acquired":true,"shares":2584,"price":13.91,"value":35943.44,"ownership":{"direct":true},"balance_after":2594140,"source":{"system":"sec-edgar","filing":"0001104659-23-085603","document":"tm2322388-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923085603/tm2322388-1_4seq1.xml","form_type":"4"}},{"id":1821591,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-28T12:00:09.000Z","date":"2023-07-27","kind":"purchase","planned":false,"acquired":true,"shares":1556,"price":13.98,"value":21752.88,"ownership":{"direct":true},"balance_after":2591556,"source":{"system":"sec-edgar","filing":"0001104659-23-085087","document":"tm2322292-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923085087/tm2322292-1_4seq1.xml","form_type":"4"}},{"id":1822281,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T10:52:12.000Z","date":"2023-07-26","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":13.97,"value":139700.0,"ownership":{"direct":true},"balance_after":2590000,"source":{"system":"sec-edgar","filing":"0001104659-23-084523","document":"tm2322208-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923084523/tm2322208-1_4seq1.xml","form_type":"4"}},{"id":1824277,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-24T20:45:13.000Z","date":"2023-07-21","kind":"purchase","planned":false,"acquired":true,"shares":2844,"price":14.61,"value":41550.84,"ownership":{"direct":true},"balance_after":2580000,"source":{"system":"sec-edgar","filing":"0001104659-23-083470","document":"tm2321778-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923083470/tm2321778-1_4seq1.xml","form_type":"4"}},{"id":1824276,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-24T20:45:13.000Z","date":"2023-07-20","kind":"purchase","planned":false,"acquired":true,"shares":5394,"price":14.4,"value":77673.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.10 to $14.42. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2577156,"source":{"system":"sec-edgar","filing":"0001104659-23-083470","document":"tm2321778-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923083470/tm2321778-1_4seq1.xml","form_type":"4"}},{"id":1825936,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-20T10:30:46.000Z","date":"2023-07-19","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":14.84,"value":118720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.76 to $14.88. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2571762,"source":{"system":"sec-edgar","filing":"0001104659-23-082536","document":"tm2321693-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923082536/tm2321693-2_4seq1.xml","form_type":"4"}},{"id":1826989,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-19T12:06:35.000Z","date":"2023-07-18","kind":"purchase","planned":false,"acquired":true,"shares":9149,"price":14.84,"value":135771.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.71 to $14.94. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2563762,"source":{"system":"sec-edgar","filing":"0001104659-23-082196","document":"tm2321610d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923082196/tm2321610d1_4seq1.xml","form_type":"4"}},{"id":1830402,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-13T12:30:18.000Z","date":"2023-07-12","kind":"purchase","planned":false,"acquired":true,"shares":3285,"price":15.09,"value":49570.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.05 to $15.11. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2554613,"source":{"system":"sec-edgar","filing":"0001104659-23-080572","document":"tm2321205d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923080572/tm2321205d1_4seq1.xml","form_type":"4"}},{"id":1831036,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-12T12:30:08.000Z","date":"2023-07-11","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":15.36,"value":153600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.25 to $15.46. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2551328,"source":{"system":"sec-edgar","filing":"0001104659-23-080178","document":"tm2321109-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923080178/tm2321109-1_4seq1.xml","form_type":"4"}},{"id":1832332,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-10T12:00:21.000Z","date":"2023-07-07","kind":"purchase","planned":false,"acquired":true,"shares":8948,"price":15.19,"value":135920.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.07 to $15.19. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2541328,"source":{"system":"sec-edgar","filing":"0001104659-23-079339","document":"tm2320922-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923079339/tm2320922-1_4seq1.xml","form_type":"4"}},{"id":1833056,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T12:04:33.000Z","date":"2023-07-06","kind":"purchase","planned":false,"acquired":true,"shares":3179,"price":15.01,"value":47716.79,"ownership":{"direct":true},"balance_after":2532380,"source":{"system":"sec-edgar","filing":"0001104659-23-078942","document":"tm2320821-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923078942/tm2320821-2_4seq1.xml","form_type":"4"}},{"id":1834158,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T11:45:13.000Z","date":"2023-07-05","kind":"purchase","planned":false,"acquired":true,"shares":1176,"price":15.52,"value":18251.52,"ownership":{"direct":true},"balance_after":2529201,"source":{"system":"sec-edgar","filing":"0001104659-23-078475","document":"tm2320683d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923078475/tm2320683d1_4seq1.xml","form_type":"4"}},{"id":1843569,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-27T12:45:52.000Z","date":"2023-06-26","kind":"purchase","planned":false,"acquired":true,"shares":16760,"price":16.46,"value":275869.6,"ownership":{"direct":true},"balance_after":2528025,"source":{"system":"sec-edgar","filing":"0001104659-23-075031","document":"tm2319737-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923075031/tm2319737-2_4seq1.xml","form_type":"4"}},{"id":1844391,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-26T12:45:28.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":73175,"price":17.43,"value":1275440.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $16.9149 to $17.7559. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2511265,"source":{"system":"sec-edgar","filing":"0001104659-23-074561","document":"tm2319640-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923074561/tm2319640-1_4seq1.xml","form_type":"4"}},{"id":1845466,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-23T12:59:48.000Z","date":"2023-06-22","kind":"purchase","planned":false,"acquired":true,"shares":6999,"price":17.73,"value":124092.27,"ownership":{"direct":true},"balance_after":2438090,"source":{"system":"sec-edgar","filing":"0001104659-23-074060","document":"tm2319541d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923074060/tm2319541d1_4seq1.xml","form_type":"4"}},{"id":1845465,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-23T12:59:48.000Z","date":"2023-06-21","kind":"purchase","planned":false,"acquired":true,"shares":6091,"price":17.71,"value":107871.61,"ownership":{"direct":true},"balance_after":2431091,"source":{"system":"sec-edgar","filing":"0001104659-23-074060","document":"tm2319541d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923074060/tm2319541d1_4seq1.xml","form_type":"4"}},{"id":1849949,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T12:25:08.000Z","date":"2023-06-16","kind":"purchase","planned":false,"acquired":true,"shares":12700,"price":17.75,"value":225425.0,"ownership":{"direct":true},"balance_after":2425000,"source":{"system":"sec-edgar","filing":"0001104659-23-072614","document":"tm2319007-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923072614/tm2319007-4_4seq1.xml","form_type":"4"}},{"id":1852665,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T10:46:53.000Z","date":"2023-06-15","kind":"purchase","planned":false,"acquired":true,"shares":31724,"price":17.71,"value":561832.04,"ownership":{"direct":true},"balance_after":2412300,"source":{"system":"sec-edgar","filing":"0001104659-23-071869","document":"tm2318934-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923071869/tm2318934-1_4seq1.xml","form_type":"4"}},{"id":1852664,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":34047,"kind":"person","name":"Mosseri Marlio Charles","position":1,"cik":"0001806384","reported_name":"Mosseri Marlio Charles","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T10:46:53.000Z","date":"2023-06-15","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":17.54,"value":7016.0,"ownership":{"direct":true},"balance_after":2380576,"source":{"system":"sec-edgar","filing":"0001104659-23-071869","document":"tm2318934-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923071869/tm2318934-1_4seq1.xml","form_type":"4"}}]}